Dosimetry
| Patient blood identifier | Octreotate-avid tumor volume at treatment (cm3) | Administered activity (MBq) | Cumulative absorbed dose to blood at 72 h (mGy) | Cumulative absorbed dose to blood at 2 h (mGy) | Absorbed dose to spleen (mGy) | Absorbed dose to bone marrow (mGy) | Absorbed dose to tumor (mGy)* |
| P1.1 | 640 | 9,000 | 40 | 10 | 2,800 | 210 | 37,000 |
| P1.2 | 700 | 7,000 | 22 | 7 | 3,600 | 210 | 31,000 |
| P1.3 | 720 | 8,000 | 33 | 12 | 2,000 | 200 | 23,000 |
| P2.2 | 3,100 | 10,000 | 57 | 16 | 3,200 | 370 | 30,000 |
| P2.3 | 3,300 | 7,900 | 52 | 14 | 3,400 | 410 | 24,000 |
| P2.5 | 3,000 | 7,800 | 37 | 8 | ND | ND | ND |
| P3.3 | 420 | 9,300 | 55 | 22 | 3,300 | 270 | 14,000 |
| P3.4 | 240 | 6,500 | 24 | 11 | 1,700 | 190 | 13,000 |
| P4.1 | 94 | 7,100 | ND | ND | ND | ND | ND |
| P5.1 | 130 | 6,900 | ND | ND | 1,700 | 250 | 12,000 |
| P6.1 | 1,200 | 7,700 | 45 | 11 | 10,000 | 190 | 46,000 |
| P7.3 | ND | ND | ND | 17 | ND | ND | ND |
| P8.3 | 29 | 8,600 | ND | ND | 6,100 | 200 | 6,000 |
| P9.3 | 30 | 6,800 | ND | ND | 3,400 | 280 | 7,000 |
| P10.5 | 110 | 8,400 | 52 | 21 | 5,100 | 280 | 20,000 |
| P11.6 | 900 | 6,700 | ND | ND | 1,900 | 170 | 18,000 |
↵* For multiple lesions, lesion with highest value was used.
ND = not determined.
Patients are numbered from P1 to P11 followed by treatment cycle number.